Topic:
Chutes and Ladders
Latest Headlines
Latest Headlines
Third Rock Ventures adds biotech veterans to team
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney ( email | Twitter ) or Emily Mullin ( email |...
Congressional Repubs challenge FDA on deputy commissioner's exit
Just a few months after Leona Brenner-Gati was named Acting Deputy Commissioner for Medical Products and Tobacco to replace the outgoing Steven Spielberg, who served only a brief stint at the post, Brenner-Gati is gone as well.
AbbVie research chief heads for the exits, amid rash of top R&D departures
AbbVie filed forms with the SEC on Friday saying that John Leonard, the company's senior vice president and CSO, will be leaving in the coming months.
AbbVie's senior R&D exec Leonard joins exodus from the top ranks
The epidemic of retirements among top R&D executives is continuing with the news that AbbVie's senior researcher is headed for the exits. AbbVie filed forms with the SEC on Friday saying that John Leonard, the company's senior vice president and CSO will be leaving in the coming months. And the company says that one of his last acts will be advising the company on his successor.
Dunsire out as Takeda rolls Millennium into its global R&D operations
CEO Deborah Dunsire is retiring from Millennium, the unit Takeda bought about 5 years ago, as Millennium's oncology R&D is rolled up into the parent company's global research organization.
UPDATED: Deborah Dunsire exits as Takeda cuts CEO role in Millennium shakeup
Millennium CEO Deborah Dunsire is retiring and her business development chief Anna Protopapas will step in to head the oncology business of Takeda Pharmaceutical. The Japanese drugmaker revealed the management shakeup in a terse announcement today.
Moderna taps biotech legend Henri Termeer for board of directors
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney ( email | Twitter ) or Emily Mullin ( email |...
Ex-Genzyme chief Termeer joins board at Cambridge biotech
Moderna, which struck a major development deal with AstraZeneca just months after it shed stealth status, has landed former Genzyme CEO Henri Termeer for the board of directors
Biotech legend Termeer joins the board at Moderna
The biotech, which struck a major development deal with AstraZeneca just months after it shed stealth status, has landed former Genzyme CEO Henri Termeer for the board of directors.
Symonds steps down as Novartis CFO, Kirsch takes over
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney ( email | Twitter ) or Emily Mullin ( email |...
